Kwality Pharmaceuticals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹157.11 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.28 per cent from ₹123.44 crore. This corresponds to a year-on-year *(YoY) growth of 35.81 per cent.
Operating Profit
Operating Profit stands at ₹38.76 crore, reflecting a quarter-on-quarter *(QoQ) increase of 33.10 per cent from ₹29.12 crore. This corresponds to a year-on-year *(YoY) growth of 49.71 per cent.
PBDT
PBDT stands at ₹36.92 crore, reflecting a quarter-on-quarter *(QoQ) increase of 35.89 per cent from ₹27.17 crore. This corresponds to a year-on-year *(YoY) growth of 52.81 per cent.
Profit Before Tax
Profit Before Tax stands at ₹31.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 41.66 per cent from ₹22.35 crore. This corresponds to a year-on-year *(YoY) growth of 66.02 per cent.
Net Profit
Net Profit stands at ₹25.31 crore, reflecting a quarter-on-quarter *(QoQ) increase of 58.19 per cent from ₹16.00 crore. This represents a 74.79 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Kwality Pharmaceuticals Ltd News
Kwality Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Kwality Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Kwality Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Kwality Pharmaceuticals Ltd Financial Reports
Kwality Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Kwality Pharma | -2.29% | 0.60% | -0.16% | 70.12% | 151.78% | 131.98% |
| Advanced Enzyme | 0.03% | 1.41% | -1.66% | -5.84% | 6.35% | -8.91% |
| Morepen Labs. | 5.21% | 6.23% | 3.61% | 35.35% | 61.18% | -6.01% |
| Dishman Carbogen | 2.15% | 0.89% | 11.54% | 3.70% | -8.72% | -25.08% |
| Hikal | 2.30% | 4.07% | 3.42% | 17.66% | 16.15% | -31.58% |
| Panacea Biotec | -1.51% | -6.04% | -21.49% | 17.34% | 20.71% | 2.11% |
| Sai Parenteral's | 4.54% | 2.11% | -3.82% | 15.79% | 38.41% | 38.41% |
Company Info
Company Information
Executive Director & MD : Ramesh Arora
E D & Wholetime Director : Ajay Arora
Executive Director / Whole Time Director / CFO : Aditya Arora
E D & Wholetime Director : Geeta Arora
E D & Wholetime Director : Anju Arora
Independent Non Exe. Director : Kartik Kapur
Independent Non Exe. Director : Prashanth Vellanki
Independent Non Exe. Director : Vinod Kumar Sharma
Company Sec. & Compli. Officer : Gurpreet Kaur
Independent Non Exe. Director : Bhavesh Mahajan
Independent Non Exe. Director : Preet Mohinder S Bedi